Morgan Stanley Initiates Pine Labs Coverage with Equal-Weight Rating and ₹260 Price Target

1 min read     Updated on 23 Dec 2025, 09:18 AM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Morgan Stanley has begun research coverage on Pine Labs Limited, a prominent Indian fintech company. The global investment bank assigned an 'Equal-weight' rating to Pine Labs' stock with a price target of ₹260.00. This neutral stance suggests the stock is expected to perform in line with market or sector benchmarks. The coverage initiation by Morgan Stanley is significant for Pine Labs, potentially increasing institutional investor interest and market visibility.

28007332

*this image is generated using AI for illustrative purposes only.

Morgan Stanley has initiated research coverage on Pine Labs Limited, one of India's prominent fintech companies, with significant implications for investor sentiment and market positioning.

Morgan Stanley's Coverage Initiation

The global investment bank has assigned an 'Equal-weight' rating to Pine Labs' stock, accompanied by a price target that provides clear guidance for potential investors.

Parameter Details
Rating Equal-weight
Price Target ₹260.00
Initiating Firm Morgan Stanley

Investment Rating Implications

The Equal-weight rating from Morgan Stanley suggests a neutral stance on the stock's near-term performance prospects. This rating category typically indicates that the analyst expects the stock to perform in line with the broader market or sector benchmarks over the investment period. The ₹260.00 price target provides investors with a specific valuation benchmark for assessing the stock's potential upside or downside from current market levels.

Market Significance

The initiation of coverage by Morgan Stanley represents a notable development for Pine Labs, as it brings the company under the research umbrella of one of the world's leading investment banks. This formal coverage may increase institutional investor interest and provide enhanced visibility for the fintech company in global markets. Research coverage from major investment banks often serves as a catalyst for improved liquidity and broader investor participation in a stock.

Historical Stock Returns for Pine Labs

1 Day5 Days1 Month6 Months1 Year5 Years
+1.22%+5.49%+1.71%-5.26%-5.26%-5.26%
Pine Labs
View in Depthredirect
like16
dislike

Pine Labs Board Approves Secretarial Auditors Appointment and Postal Ballot Resolutions

2 min read     Updated on 17 Dec 2025, 02:30 PM
scanx
Reviewed by
Suketu GScanX News Team
Overview

Pine Labs Limited announced key board decisions from its December 17, 2025 meeting, including the appointment of M/s. Makarand M. Joshi Co. as secretarial auditors for a five-year term and approval of postal ballot resolutions covering ESOP scheme amendments, subsidiary employee benefits, and property charge creation, all subject to shareholder approval under SEBI regulatory compliance.

27507647

*this image is generated using AI for illustrative purposes only.

Pine Labs Limited announced the outcome of its board meeting held on December 17, 2025, addressing key corporate governance matters and shareholder approvals. The meeting, which commenced at 1:30 PM and concluded at 1:48 PM, resulted in significant decisions regarding the company's audit framework and employee benefit schemes.

Secretarial Auditors Appointment

The board approved the appointment of M/s. Makarand M. Joshi Co., Practising Company Secretaries, as the company's secretarial auditors for a five-year term. This appointment covers the period from Financial Year 2025-26 to Financial Year 2029-30, subject to shareholder approval.

Parameter: Details
Audit Firm: M/s. Makarand M. Joshi Co.
Term Period: FY 2025-26 to FY 2029-30
Duration: 5 consecutive years
Approval Status: Subject to shareholder approval

M/s. Makarand M. Joshi Co. (MMJC) brings over 25 years of excellence in corporate governance and compliance. The firm is widely recognized for its expertise in secretarial audits, compliance audits, and due diligence across various sectors including banking, financial services, IT/Telecom, pharmaceuticals, FMCG, and infrastructure. MMJC offers comprehensive advisory and compliance services under Corporate Laws, SEBI Regulations, FEMA Regulations, and Merger & Acquisition frameworks.

Postal Ballot Resolutions

The board approved the issuance of a postal ballot notice for seeking shareholder approval on four key resolutions:

Resolution Type: Details
ESOP Scheme Amendment: Ratification and amendment in Pine Labs Employee Stock Option Plan 2025
Subsidiary ESOP Extension: Extension of ESOP benefits to employees of subsidiary companies
Auditors Appointment: Appointment of secretarial auditors for five-year term
Property Charges: Creation of charges, mortgages, and hypothecation on properties under Section 180(1)(a)

Regulatory Compliance

The decisions were made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided detailed information in compliance with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

The postal ballot notice, including other related information required under the Companies Act, 2013, and Listing Regulations, will be published and communicated in due course. All information will be made available on the company's website at https://www.pinelabs.com/investor-relations/corporate-announcements .

Corporate Details

Pine Labs Limited operates from its registered office at Unit no. 408, 4th Floor, Time Tower, MG Road, DLF QE, Gurgaon-122002, Haryana, with its corporate office located at Unit no. 1604, 15th Floor, A Wing, Plot no. C-70, The Capital, G Block, BKC Bandra East, Mumbai-400061. The company secretary and compliance officer, Neerav Mehta (Membership Number: A20949), signed the regulatory filing.

Corporate Information: Details
BSE Scrip Code: 544606
NSE Symbol: PINELABS
CIN: L67100HR1998PLC033312
Company Secretary: Neerav Mehta (A20949)

Historical Stock Returns for Pine Labs

1 Day5 Days1 Month6 Months1 Year5 Years
+1.22%+5.49%+1.71%-5.26%-5.26%-5.26%
Pine Labs
View in Depthredirect
like18
dislike
More News on Pine Labs
Explore Other Articles
237.69
+2.86
(+1.22%)